Skip to main content
Clinical Trials/NCT00758550
NCT00758550
Completed
Phase 4

Visual Function After Bilateral Implantation of AcrySof® Toric

Alcon Research1 site in 1 country60 target enrollmentApril 2007
ConditionsVisual Function

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Visual Function
Sponsor
Alcon Research
Enrollment
60
Locations
1
Primary Endpoint
Uncorrected Visual Acuity (UCVA)
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

The objective of this study was to evaluate visual function of AcrySof Toric and AcrySof Natural Intraocular Lenses (IOLs) following implant for replacement of cataract.

Registry
clinicaltrials.gov
Start Date
April 2007
End Date
June 2008
Last Updated
16 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Bilateral cataracts
  • 40\~80 years of age
  • 4 Days - 1 Week interval between a single patient's surgery
  • dilated pupil size (in dim light) ≥ 4.0 mm
  • Anticipated correction with an IOL of +10 Diopters \~ +25 Diopters
  • 0.75 - 2.0 Diopters of astigmatism preoperatively as measured by Keratometry readings

Exclusion Criteria

  • Preoperative ocular pathology
  • Previous intraocular or corneal surgery
  • An increased risk for complications which could require vitreoretinal surgery
  • Corneal irregularities
  • Corneal opacities
  • Current contact lens usage(within 6 months prior to first surgery)

Outcomes

Primary Outcomes

Uncorrected Visual Acuity (UCVA)

Time Frame: 6 Months after surgery

Uncorrected Visual Acuity (UCVA) from surgery measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better visual acuity.

Secondary Outcomes

  • Questionnaire Results(6 Months)

Study Sites (1)

Loading locations...

Similar Trials